This inventor holds 1 USPTO granted patent. Top assignee: Xi'an Jiaotong University. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Bingjie Jiang - Innovator in Pharmaceutical Composition
Introduction
Bingjie Jiang is a notable inventor based in Jiangsu, China. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of innovative proteins that target specific endonucleases.
Latest Patents
Bingjie Jiang holds a patent for a "Membrane-type metalloprotease inhibitory protein and pharmaceutical composition containing the same, and respective uses thereof." This patent discloses a membrane-type metalloprotease inhibitory protein T1 and its applications in preparing drugs that target MT1-MMP or TACE endonuclease. Additionally, it includes an antitumor pharmaceutical composition comprising BHK-21 cells and an artificial basal membrane that expresses the T1 protein. He has 1 patent to his name.
Career Highlights
Bingjie Jiang is affiliated with Xi'an Jiaotong University, where he continues to engage in research and development in the pharmaceutical field. His work focuses on creating innovative solutions for medical challenges.
Collaborations
He has collaborated with notable colleagues, including Meng Huee Lee and Jian Liu, contributing to advancements in their shared field of expertise.
Conclusion
Bingjie Jiang's work exemplifies the intersection of innovation and pharmaceutical research, showcasing his commitment to developing effective medical solutions. His contributions are paving the way for future advancements in drug development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile